<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Eur J Med Res</journal-id>
      <journal-id journal-id-type="iso-abbrev">Eur. J. Med. Res</journal-id>
      <journal-title-group>
        <journal-title>European Journal of Medical Research</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0949-2321</issn>
      <issn pub-type="epub">2047-783X</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">20156749</article-id>
      <article-id pub-id-type="pmc">3521370</article-id>
      <article-id pub-id-type="publisher-id">2047-783X-14-S4-162</article-id>
      <article-id pub-id-type="doi">10.1186/2047-783X-14-S4-162</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Dermatomyositis masquerading as pulmonary embolism</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Mroz</surname>
            <given-names>RM</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>Robmroz@wp.pl</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Korniluk</surname>
            <given-names>M</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Chyczewska</surname>
            <given-names>E</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Chest Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland</aff>
      <pub-date pub-type="collection">
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>7</day>
        <month>12</month>
        <year>2009</year>
      </pub-date>
      <volume>14</volume>
      <issue>Suppl 4</issue>
      <supplement>
        <named-content content-type="supplement-title">International Conference 'Advances in Pneumology&#x2019;</named-content>
        <named-content content-type="supplement-editor">Mieczyslaw Pokorski, Adrian Gillissen, Kurt Rasche</named-content>
      </supplement>
      <fpage>162</fpage>
      <lpage>164</lpage>
      <permissions>
        <copyright-statement>Copyright &#xA9;2009 I. Holzapfel Publishers</copyright-statement>
        <copyright-year>2009</copyright-year>
        <copyright-holder>I. Holzapfel Publishers</copyright-holder>
      </permissions>
      <self-uri xlink:href="http://www.eurjmedres.com/content/14/S4/162"/>
      <abstract>
        <p>A 61-year-old Caucasian was admitted to Department of Chest Diseases and Tuberculosis, Medical University of Bialystok, Poland for progressive muscle weakness and weight loss. Eighteen months prior to admission, the patient had been diagnosed with pulmonary embolism. At that point he was started on Enoxaparin QD. Past medical history was unremarkable. In the interim, the patient developed fever, myalgia and progressive dyspnea. Physical examination on admission revealed a rash on his upper torso and back, and the extensor surfaces of all four extremities. Laboratory values included CPK 8229, MB fraction 219, LDH 981. Chest X-ray and CT scan revealed bilateral patchy consolidations and ground-glass opacities. EMG was consistent with myositis. The patient was started on solumedrol 40 mg i.v., b.i.d., and then switched to prednisone 40 mg b.i.d. His symptoms and muscle strength improved remarkably. The patient was discharged with prednisone with an outpatient follow up.</p>
      </abstract>
      <kwd-group>
        <kwd>dermatomyositis</kwd>
        <kwd>polymyositis</kwd>
        <kwd>pulmonary embolism</kwd>
      </kwd-group>
      <conference>
        <conf-date>12-14 June 2009</conf-date>
        <conf-name>International Conference 'Advances in Pneumology&#x2019;</conf-name>
        <conf-loc>Leipzig, Germany</conf-loc>
      </conference>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Dermatomyositis (DM) is an idiopathic inflammatory myopathy with characteristic skin manifestations [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. The prevalence of the disease is 1-10 cases per million in adults and 1-3.2 cases per million in children [<xref ref-type="bibr" rid="B3">3</xref>]. In 1975, Bohan and Peter [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>] first suggested a set of criteria to aid in the diagnosis and classification of polymyositis (PM) and DM as follows: progressive proximal symmetrical weakness, elevated levels of muscle enzymes, an abnormal finding on electromyography, an abnormal finding on muscle biopsy, and skin manifestations which are compatible with cutaneous disease (Table <xref ref-type="table" rid="T1">1</xref>).</p>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p>Diagnostic criteria of polymyositis and dermatomyositis, according to Bohan and Peter [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>].</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" colspan="4">1. Progressive symmetrical general muscle weakness</th>
            </tr>
            <tr>
              <th align="left" colspan="4">2. Typical for myositis histopathology findings</th>
            </tr>
            <tr>
              <th align="left" colspan="4">3. Elevated plasma level of CK and/or aldolase</th>
            </tr>
            <tr>
              <th align="left" colspan="4">4. EMG findings typical for primary myopathy</th>
            </tr>
            <tr>
              <th align="left" colspan="4">5. Typical skin findings (Gottron's sign, helitrope rash of eyelids, upper torso, arms)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="center" colspan="4">Number of symptoms 5</td>
            </tr>
            <tr>
              <td colspan="4">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left">
                <bold>Diagnosis</bold>
              </td>
              <td align="left">
                <bold>Confirmed</bold>
              </td>
              <td align="left">
                <bold>Suggestive</bold>
              </td>
              <td align="left">
                <bold>Possible</bold>
              </td>
            </tr>
            <tr>
              <td align="left">
                <bold>PM</bold>
              </td>
              <td align="left">4</td>
              <td align="left">3</td>
              <td align="left">2</td>
            </tr>
            <tr>
              <td align="left">
                <bold>DM</bold>
              </td>
              <td align="left">3-4</td>
              <td align="left">2</td>
              <td align="left">1</td>
            </tr>
            <tr>
              <td colspan="4">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" colspan="4">plus characteristic skin findings</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec>
      <title>Case Report</title>
      <p>The study was performed according to the standards set by the Helsinki Declaration of 1975, regarding the Human Research and was approved by an institutional Ethics Committee. Informed consent was obtained from the patient described in this article.</p>
      <p>A 61-year-old Caucasian male was admitted to Department of Chest Diseases and Tuberculosis, Medical University of Bialystok for progressive muscle weakness. The patient also developed a rash on his upper torso and back, and the extensor surfaces of all four extremities. The patient complained of generalized muscle weakness that had been present for several months but had now progressed remarkably. One and half year prior to admission, he had been admitted to the department for recurrent hemoptysis and was diagnosed with pulmonary embolism, fitting all clinical and radiological criteria. At that point he was started on enoxaparin QD. Past medical history and surgical history were unremarkable, and the patient denied the use of any tobacco or recreational drugs. He retired 6 years prior to admission. Hemoptysis stopped after first two weeks of hyperfractionated heparin treatment. He admitted to losing about 53 kilos in 18 months prior to admission, with accompanying decrease in appetite. In the interim, he developed fever, myalgia, and progressive dyspnea. He denied any previous episodes similar to this, and reported no family history of musculoskeletal disease. Physical examination revealed an ill-appearing man with an oral temperature of 38.2&#xB0;C, a pulse rate of 60 beats/min, and normal blood pressure. His skin had purple confluent discoloration and swelling of the eyelids (Figure <xref ref-type="fig" rid="F1">1A</xref>), the V-shape rash with areas of hyperpigmentation of his upper torso (Figure <xref ref-type="fig" rid="F1">1B</xref>). The rash was also present on his shoulders (Figure <xref ref-type="fig" rid="F2">2A</xref>), and erythematous papules over joints (Figure <xref ref-type="fig" rid="F2">2B</xref>). Hypertrophic changes of palms and fingers (Figure <xref ref-type="fig" rid="F2">2C</xref>), were also found. Subtle dry cracles and wheezing were found on auscultation. Chest X-ray and CT scan revealed bilateral patchy consolidations and ground-glass opacities (Figure <xref ref-type="fig" rid="F3">3A</xref> and <xref ref-type="fig" rid="F3">3B</xref>). On admission, laboratory values included CPK 8229 U/l, MB fraction 219 U/l, LDH 981 U/l, and D-dimer 0.96 ng/ml. EMG was consistent with myositis. At admission, the patient was started on solumedrol 40 mg i.v, b.i.d., and then switched to prednisone 40 mg b.i.d. After two weeks of therapy, the patient's symptoms improved remarkably. His muscle strength improved and he was able to participate in physical therapy. The patient was discharged back to his facility with prednisone with an outpatient follow up.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Skin manifestations I</bold>. Panel A - Heliotrope rash and Panel B - Violet discoloration and swelling of the eyelids.</p>
        </caption>
        <graphic xlink:href="2047-783X-14-S4-162-1"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>Skin manifestations II</bold>. Panel A - Rash on shoulders, Panel B - Erythematous papules over joints - 'Gottron's sign', and Panel C - Hypertrophic changes of palms and fingers - 'Machanic's hands'.</p>
        </caption>
        <graphic xlink:href="2047-783X-14-S4-162-2"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p><bold>X-Ray (Panel A) and HRCT (Panel B) findings</bold>. Bilateral patchy consolidations and ground-glass opacities.</p>
        </caption>
        <graphic xlink:href="2047-783X-14-S4-162-3"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>This patient was diagnosed with dermatomyositis, fitting 4 out of the five diagnostic criteria, as outlined above: proximal muscle weakness, CPK and LDH elevations, consistent with myositis EMG, and skin manifestations [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. The latter were as follows: purple confluent discoloration and swelling of the eyelids - heliotrope rush, the V-shape rash with areas of hyperpigmentation of his upper torso and shoulders, back, knees, and erythematous papules over joints - 'Gottron's sign', and hypertrophic changes of palms and fingers - 'Mechanic's hands'. The diagnosis is confirmed if a patient presents with at least 4 diagnostic criteria for PM or 3 for DM [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. The fifth criterion which is confirmation of inflammatory infiltrations on muscle biopsy was not done in this case. Since our patient exhibited clinical and laboratory findings consistent with inflammatory myopathy with skin manifestations present, our diagnosis was consistent with dermatomyositis.</p>
      <p>The cause of the disease remains unknown. Altered immune response towards viral infection is considered to play a major role [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Vascular deposits of immune complexes and complement, leading to endothelial cell injury and small vessel obstruction are most important pathogenetic factors underlying the disease [<xref ref-type="bibr" rid="B6">6</xref>]. The muscles and endothelial cells are infiltrated with predominance of T CD4+ cells in DM and T CD8+ cells in PM patients [<xref ref-type="bibr" rid="B6">6</xref>]. An association of tumor necrosis factor alpha and HLA polymorphisms with adult dermatomyositis has recently been reported [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. Our patient exhibited all reported skin manifestations of DM which were: a heliotrope rash, which is a purple discoloration and swelling of the eyelids, Gottron's sign demonstrated with erythematous papules over joints, and mechanic's hands, which are: erythematous and hypertrophic skin changes of palms and fingers [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B5">5</xref>]. Hemoptysis, progressive dyspnea, subtle dry cracles and wheezing on auscultation, with bilateral patchy consolidations and ground-glass opacities on chest X-ray and CT scans confirmed lung interstitium disease association in our case. Hemoptysis and pulmonary embolism, lack of significant muscle weakness at the onset of the disease masqueraded underlying DM and delayed proper diagnosis. Lung involvement has been reported in minority of PM and DM cases, influencing the course and worsening prognosis in most of the cases [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. An association with other connective tissue disorders (overlap syndrome) and malignancy has also been reported [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B13">13</xref>]. The course of the disease is usually steadily progressive, leading to profound symmetrical skeletal muscle weakness of all extremities. Patient management includes careful evaluation for underlying malignancy, physical therapy, antihistamines, sunscreen, and oral corticosteroids [<xref ref-type="bibr" rid="B14">14</xref>]. Alternative therapies include corticosteroid-sparing agents, cytotoxic drugs, and more recently monoclonal antibodies with cutaneous lesions treatment [<xref ref-type="bibr" rid="B14">14</xref>-<xref ref-type="bibr" rid="B18">18</xref>]. Irresponsive disease, delay in diagnosis and the underlying malignancies worsen disease prognosis.</p>
    </sec>
    <sec>
      <title>Conflicts of interest</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Krathen</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Fiorentino</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Werth</surname>
            <given-names>VP</given-names>
          </name>
          <article-title>Dermatomyositis</article-title>
          <source>Curr Dir Autoimmun</source>
          <year>2008</year>
          <volume>10</volume>
          <fpage>313</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="pmid">18460893</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Targoff</surname>
            <given-names>IN</given-names>
          </name>
          <article-title>Dermatomyositis and polymyositis</article-title>
          <source>Curr Probl Dermatol</source>
          <year>1991</year>
          <volume>3</volume>
          <fpage>131</fpage>
          <lpage>180</lpage>
          <pub-id pub-id-type="doi">10.1016/1040-0486(91)90009-S</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Marie</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Hatron</surname>
            <given-names>PY</given-names>
          </name>
          <name>
            <surname>Levesque</surname>
            <given-names>H</given-names>
          </name>
          <etal/>
          <article-title>Influence of age on characteristics of polymyositis and dermatomyositis in adults</article-title>
          <source>Medicine (Baltimore)</source>
          <year>1999</year>
          <volume>78</volume>
          <issue>3</issue>
          <fpage>139</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="doi">10.1097/00005792-199905000-00001</pub-id>
          <pub-id pub-id-type="pmid">10352646</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bohan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Peter</surname>
            <given-names>JB</given-names>
          </name>
          <article-title>Polymyositis and dermatomyositis (first of two parts)</article-title>
          <source>N Engl J Med</source>
          <year>1975</year>
          <volume>292</volume>
          <issue>7</issue>
          <fpage>344</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM197502132920706</pub-id>
          <pub-id pub-id-type="pmid">1090839</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bohan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Peter</surname>
            <given-names>JB</given-names>
          </name>
          <article-title>Polymyositis and dermatomyositis (second of two parts)</article-title>
          <source>N Engl J Med</source>
          <year>1975</year>
          <volume>292</volume>
          <issue>8</issue>
          <fpage>403</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM197502202920807</pub-id>
          <pub-id pub-id-type="pmid">1089199</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dalakas</surname>
            <given-names>MC</given-names>
          </name>
          <article-title>Molecular immunology and genetics of inflammatory muscle diseases</article-title>
          <source>Arch Neurol</source>
          <year>1998</year>
          <volume>55</volume>
          <issue>12</issue>
          <fpage>1509</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="doi">10.1001/archneur.55.12.1509</pub-id>
          <pub-id pub-id-type="pmid">9865793</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Werth</surname>
            <given-names>VP</given-names>
          </name>
          <name>
            <surname>Callen</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Ang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Sullivan</surname>
            <given-names>KE</given-names>
          </name>
          <article-title>Associations of tumor necrosis factor alpha and HLA polymorphisms with adult dermatomyositis: implications for a unique pathogenesis</article-title>
          <source>J Invest Dermatol</source>
          <year>2002</year>
          <volume>119</volume>
          <issue>3</issue>
          <fpage>617</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1523-1747.2002.01869.x</pub-id>
          <pub-id pub-id-type="pmid">12230503</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Efthimiou</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implications</article-title>
          <source>Semin Arthritis Rheum</source>
          <year>2006</year>
          <volume>36</volume>
          <issue>3</issue>
          <fpage>168</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="doi">10.1016/j.semarthrit.2006.07.003</pub-id>
          <pub-id pub-id-type="pmid">16970978</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Fujisawa</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Suda</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Enomoto</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Ide</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Toyoshima</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Uchiyama</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tamura</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Ida</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yagi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Yasuda</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Genma</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Hayakawa</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Chida</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis</article-title>
          <source>J Rheumatol</source>
          <year>2005</year>
          <volume>32</volume>
          <issue>1</issue>
          <fpage>58</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="pmid">15630726</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yokoyama</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sakamoto</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Shida</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kinoshita</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kunou</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Karukaya</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Takamatsu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Aizawa</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Fatal rapidly progressive interstitial pneumonitis associated with amyopathic dermatomyositis and CD8 T lymphocytes</article-title>
          <source>J Intensive Care Med</source>
          <year>2005</year>
          <volume>20</volume>
          <issue>3</issue>
          <fpage>160</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1177/0885066605275391</pub-id>
          <pub-id pub-id-type="pmid">15888904</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Callen</surname>
            <given-names>JP</given-names>
          </name>
          <article-title>The value of malignancy evaluation in patients with dermatomyositis</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1982</year>
          <volume>6</volume>
          <issue>2</issue>
          <fpage>253</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/S0190-9622(82)70018-0</pub-id>
          <pub-id pub-id-type="pmid">7037882</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Chow</surname>
            <given-names>WH</given-names>
          </name>
          <name>
            <surname>Gridley</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Mellemkjaer</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>McLaughlin</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Olsen</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Fraumeni</surname>
            <given-names>JF</given-names>
            <suffix>Jr</suffix>
          </name>
          <article-title>Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark</article-title>
          <source>Cancer Causes Control</source>
          <year>1995</year>
          <volume>6</volume>
          <issue>1</issue>
          <fpage>9</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00051675</pub-id>
          <pub-id pub-id-type="pmid">7718740</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Whitmore</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Rosenshein</surname>
            <given-names>NB</given-names>
          </name>
          <name>
            <surname>Provost</surname>
            <given-names>TT</given-names>
          </name>
          <article-title>Ovarian cancer in patients with dermatomyositis</article-title>
          <source>Medicine (Baltimore)</source>
          <year>1994</year>
          <volume>73</volume>
          <issue>3</issue>
          <fpage>153</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">8190038</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Iorizzo</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Jorizzo</surname>
            <given-names>JL</given-names>
          </name>
          <article-title>The treatment and prognosis of dermatomyositis: an updated review</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2008</year>
          <volume>59</volume>
          <issue>1</issue>
          <fpage>99</fpage>
          <lpage>112</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jaad.2008.02.043</pub-id>
          <pub-id pub-id-type="pmid">18423790</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Majithia</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Harisdangkul</surname>
            <given-names>V</given-names>
          </name>
          <article-title>Mycophenolate mofetil (Cell-Cept): an alternative therapy for autoimmune inflammatory myopathy</article-title>
          <source>Rheumatology (Oxford)</source>
          <year>2005</year>
          <volume>44</volume>
          <issue>3</issue>
          <fpage>386</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1093/rheumatology/keh499</pub-id>
          <pub-id pub-id-type="pmid">15572389</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nadiminti</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Arbiser</surname>
            <given-names>JL</given-names>
          </name>
          <article-title>Rapamycin (sirolimus) as a steroid-sparing agent in dermatomyositis</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2005</year>
          <volume>52</volume>
          <issue>2 Suppl 1</issue>
          <fpage>17</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">15692505</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dalakas</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Illa</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Dambrosia</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Soueidan</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Stein</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Otero</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Dinsmore</surname>
            <given-names>ST</given-names>
          </name>
          <name>
            <surname>McCrosky</surname>
            <given-names>S</given-names>
          </name>
          <article-title>A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis</article-title>
          <source>N Engl J Med 30</source>
          <year>1993</year>
          <volume>329</volume>
          <issue>27</issue>
          <fpage>1993</fpage>
          <lpage>2000</lpage>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Levine</surname>
            <given-names>TD</given-names>
          </name>
          <article-title>Rituximab in the treatment of dermatomyositis: an open-label pilot study</article-title>
          <source>Arthritis Rheum</source>
          <year>2005</year>
          <volume>52</volume>
          <fpage>601</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1002/art.20849</pub-id>
          <pub-id pub-id-type="pmid">15692974</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
